CGB7
gene geneOn this page
Also known as CG-beta-a
Summary
CGB7 (chorionic gonadotropin subunit beta 7, HGNC:16451) is a protein-coding gene on chromosome 19q13.33, encoding Choriogonadotropin subunit beta 7 (P0DN87). Beta subunit of the human chorionic gonadotropin (hCG). hCG is a complex glycoprotein composed of two glycosylated subunits alpha and beta which are non-covalently associated.
This gene is a member of the glycoprotein hormone beta chain family and encodes the beta 7 subunit of chorionic gonadotropin (CG). Glycoprotein hormones are heterodimers consisting of a common alpha subunit and an unique beta subunit which confers biological specificity. CG is produced by the trophoblastic cells of the placenta and stimulates the ovaries to synthesize the steroids that are essential for the maintenance of pregnancy. The beta subunit of CG is encoded by 6 genes which are arranged in tandem and inverted pairs on chromosome 19q13.3 and contiguous with the luteinizing hormone beta subunit gene.
Source: NCBI Gene 94027 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 48 total
- MANE Select transcript:
NM_001385261
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16451 |
| Approved symbol | CGB7 |
| Name | chorionic gonadotropin subunit beta 7 |
| Location | 19q13.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CG-beta-a |
| Ensembl gene | ENSG00000196337 |
| Ensembl biotype | protein_coding |
| OMIM | 608826 |
| Entrez | 94027 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 8 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000596965, ENST00000597853, ENST00000598442, ENST00000684222, ENST00000880970, ENST00000880971, ENST00000929460, ENST00000929461, ENST00000929462
RefSeq mRNA: 2 — MANE Select: NM_001385261
NM_001385261, NM_033142
CCDS: CCDS33071
Canonical transcript exons
ENST00000684222 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002208205 | 49055361 | 49056595 |
| ENSE00002516685 | 49054841 | 49055008 |
| ENSE00003794470 | 49057121 | 49057248 |
| ENSE00003917409 | 49054274 | 49054605 |
| ENSE00003919791 | 49057462 | 49057749 |
Expression profiles
Bgee: expression breadth broad, 82 present calls, max score 67.74.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1714 / max 12.0524, expressed in 76 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 181984 | 0.1714 | 76 |
Top tissues by expression
112 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| lower esophagus mucosa | UBERON:0035834 | 67.74 | gold quality |
| skin of abdomen | UBERON:0001416 | 66.49 | gold quality |
| zone of skin | UBERON:0000014 | 66.04 | gold quality |
| skin of leg | UBERON:0001511 | 65.94 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 64.58 | gold quality |
| esophagus mucosa | UBERON:0002469 | 63.65 | gold quality |
| stromal cell of endometrium | CL:0002255 | 63.27 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 63.04 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 62.33 | gold quality |
| gastrocnemius | UBERON:0001388 | 61.30 | gold quality |
| muscle of leg | UBERON:0001383 | 61.18 | gold quality |
| prostate gland | UBERON:0002367 | 59.95 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 57.77 | gold quality |
| vagina | UBERON:0000996 | 57.74 | gold quality |
| right uterine tube | UBERON:0001302 | 56.50 | gold quality |
| muscle tissue | UBERON:0002385 | 56.43 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 53.27 | gold quality |
| minor salivary gland | UBERON:0001830 | 53.08 | gold quality |
| placenta | UBERON:0001987 | 52.45 | gold quality |
| esophagus | UBERON:0001043 | 50.27 | gold quality |
| pituitary gland | UBERON:0000007 | 49.30 | gold quality |
| right lung | UBERON:0002167 | 48.97 | gold quality |
| duodenum | UBERON:0002114 | 47.59 | silver quality |
| uterine cervix | UBERON:0000002 | 47.24 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 46.97 | gold quality |
| ectocervix | UBERON:0012249 | 46.58 | gold quality |
| urinary bladder | UBERON:0001255 | 46.40 | gold quality |
| adenohypophysis | UBERON:0002196 | 45.24 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 45.24 | gold quality |
| left uterine tube | UBERON:0001303 | 45.15 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-8060 | yes | 3948.62 |
| E-HCAD-5 | yes | 36.41 |
| E-ANND-3 | no | 0.97 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): TP53
Literature-anchored findings (GeneRIF, showing 2)
- Expression of the CGB7 gene is upregulated upon p53 induction in human HFF, HCT116 and DLD1 cells as well as in cell preparations enriched in human primary first-trimester trophoblasts. (PMID:22032922)
- N- and O-glycosylation patterns and functional testing of CGB7 versus CGB3/5/8 variants of the human chorionic gonadotropin (hCG) beta subunit. (PMID:32767150)
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| drosophila_melanogaster | Gpb5 | FBGN0063368 |
Paralogs (9): CGB2 (ENSG00000104818), LHB (ENSG00000104826), CGB3 (ENSG00000104827), FSHB (ENSG00000131808), TSHB (ENSG00000134200), GPHB5 (ENSG00000179600), CGB5 (ENSG00000189052), CGB8 (ENSG00000213030), CGB1 (ENSG00000267631)
Protein
Protein identifiers
Choriogonadotropin subunit beta 7 — P0DN87 (reviewed: P0DN87)
All UniProt accessions (2): A0A0F7RQF0, P0DN87
UniProt curated annotations — full annotation on UniProt →
Function. Beta subunit of the human chorionic gonadotropin (hCG). hCG is a complex glycoprotein composed of two glycosylated subunits alpha and beta which are non-covalently associated. The alpha subunit is identical to those in the pituitary gonadotropin hormones (LH, FSH and TSH). The beta subunits are distinct in each of the hormones and confer receptor and biological specificity. Has an essential role for pregnancy and maternal adaptation. Stimulates the ovaries to synthesize the steroids that are essential for the maintenance of pregnancy.
Subunit / interactions. Heterodimer of a common alpha chain identical in LH, FSH, TSH and HCG and a unique beta chain distinct in each of the hormones and confers receptor and biological specificity.
Subcellular location. Secreted.
Tissue specificity. High expression in the placenta throughout pregnancy.
Miscellaneous. Encoded by a cluster of genes that have evolved by duplication from LHB. HCG-beta is encoded by six non-allelic genes (CGB) clustered on chromosome 19q13.3 and named CGB1, CGB2, CGB3, CGB5, CGB7 and CGB8. Two specific hCGb proteins that differ by three amino acids in positions 2,4 and 117 have been described: type 1 (CGB7) and type 2 (CGB3, CGB5, CGB8). The CGB gene first arose in the common ancestor of the anthropoid primates.
Similarity. Belongs to the glycoprotein hormones subunit beta family.
RefSeq proteins (2): NP_001372190, NP_149133 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001545 | Gonadotropin_bsu | Family |
| IPR006208 | Glyco_hormone_CN | Domain |
| IPR018245 | Gonadotropin_bsu_CS | Conserved_site |
| IPR029034 | Cystine-knot_cytokine | Homologous_superfamily |
Pfam: PF00007
UniProt features (16 total): disulfide bond 6, glycosylation site 6, signal peptide 1, chain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0DN87-F1 | 78.70 | 0.46 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (6): 29–77, 43–92, 46–130, 54–108, 58–110, 113–120
Glycosylation sites (6): 33, 50, 141, 147, 152, 158
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 25 (showing top):
BENPORATH_ES_WITH_H3K27ME3, GOBP_CELL_CELL_SIGNALING, GGARNTKYCCA_UNKNOWN, GOBP_FEMALE_GAMETE_GENERATION, GOMF_SIGNALING_RECEPTOR_BINDING, GOMF_HORMONE_ACTIVITY, SMAD4_Q6, GOMF_SIGNALING_RECEPTOR_REGULATOR_ACTIVITY, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, EGR_Q6, SKIL_TARGET_GENES, ZNF563_TARGET_GENES, DESCARTES_MAIN_FETAL_TROPHOBLAST_GIANT_CELLS, DESCARTES_FETAL_KIDNEY_MESANGIAL_CELLS, GOMF_MOLECULAR_FUNCTION_ACTIVATOR_ACTIVITY
GO Biological Process (5): apoptotic process (GO:0006915), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), cell-cell signaling (GO:0007267), female gamete generation (GO:0007292)
GO Molecular Function (2): hormone activity (GO:0005179), signaling receptor binding (GO:0005102)
GO Cellular Component (3): obsolete extracellular space (GO:0005615), cytoplasm (GO:0005737), extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cell communication | 2 |
| signaling | 2 |
| cellular anatomical structure | 2 |
| programmed cell death | 1 |
| apoptotic signaling pathway | 1 |
| execution phase of apoptosis | 1 |
| cellular process | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| gamete generation | 1 |
| receptor ligand activity | 1 |
| protein binding | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A6NKQ9, B1AWI6, G7PWZ3, I6M4H4, O09108, O46482, O46483, O46641, O77805, O77835, P01229, P01230, P01231, P01232, P04651, P07434, P08751, P0DN86, P0DN87, P17490, P19794, P27767, P30984, P43021, P45646, P45657, P51500, Q04997, Q1L6U9, Q2Q1P0, Q2Q1P1, Q2Q1P2, Q3HRV3, Q3S2X5, Q6EV78, Q6HA10, Q6NT52, Q6PX77, Q7ZZV4, Q8CB67
Diamond homologs: A1BN60, A1BN61, A6NKQ9, O09108, O13050, O46430, O46482, O46483, O46641, O57340, O73824, O77805, O77835, P01222, P01223, P01224, P01225, P01226, P01227, P01228, P01229, P01230, P01231, P01232, P01235, P04651, P04652, P04837, P07434, P07732, P08751, P0DN86, P0DN87, P10256, P10257, P12656, P12837, P18427, P19794, P25330
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
48 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 37 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
231 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:49054836:CTCA:C | donor_loss | 1.0000 |
| 19:49054837:TCA:T | donor_loss | 1.0000 |
| 19:49054838:CA:C | donor_loss | 1.0000 |
| 19:49054839:A:AC | donor_gain | 1.0000 |
| 19:49054840:C:CC | donor_gain | 1.0000 |
| 19:49054839:AC:A | donor_gain | 0.9900 |
| 19:49054840:CC:C | donor_gain | 0.9900 |
| 19:49054840:CCATG:C | donor_gain | 0.9900 |
| 19:49055007:CC:C | acceptor_gain | 0.9900 |
| 19:49055007:CCCTG:C | acceptor_loss | 0.9900 |
| 19:49055008:CC:C | acceptor_gain | 0.9900 |
| 19:49055008:CCT:C | acceptor_loss | 0.9900 |
| 19:49055009:C:A | acceptor_loss | 0.9900 |
| 19:49055009:C:CC | acceptor_gain | 0.9900 |
| 19:49055009:C:T | acceptor_gain | 0.9900 |
| 19:49055010:T:A | acceptor_loss | 0.9900 |
| 19:49054614:CG:C | acceptor_gain | 0.9800 |
| 19:49054615:G:C | acceptor_gain | 0.9800 |
| 19:49055005:GCCC:G | acceptor_gain | 0.9800 |
| 19:49055006:CCC:C | acceptor_gain | 0.9800 |
| 19:49055006:CCCC:C | acceptor_gain | 0.9800 |
| 19:49055007:CCC:C | acceptor_gain | 0.9800 |
| 19:49054613:CCGTG:C | acceptor_gain | 0.9700 |
| 19:49054614:C:T | acceptor_gain | 0.9700 |
| 19:49054840:CCA:C | donor_gain | 0.9700 |
| 19:49054840:CCAT:C | donor_gain | 0.9700 |
| 19:49055004:AGCCC:A | acceptor_gain | 0.9700 |
| 19:49054601:CGGGT:C | acceptor_gain | 0.9600 |
| 19:49054615:G:GC | acceptor_gain | 0.9600 |
| 19:49054617:G:C | acceptor_gain | 0.9600 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000289437 (19:49055296 C>T), RS1000373517 (19:49058545 C>G), RS1000476557 (19:49058905 A>G), RS1000744674 (19:49057748 A>G,T), RS1000820047 (19:49057873 G>C,T), RS1002420522 (19:49056888 C>T), RS1002492591 (19:49057027 C>A,G,T), RS1002752794 (19:49056170 GC>G), RS1004507022 (19:49055698 C>G), RS1004630905 (19:49057928 T>C,G), RS1004704480 (19:49059063 G>C,T), RS1005066804 (19:49058165 A>T), RS1006600357 (19:49056282 G>A,T), RS1008303229 (19:49055817 C>T), RS1008575791 (19:49058630 G>A)
Disease associations
OMIM: gene MIM:608826 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006979_686 | Heel bone mineral density | 3.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009270 | heel bone mineral density |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases methylation, increases expression | 2 |
| perfluorooctane sulfonic acid | decreases reaction, increases expression | 1 |
| seocalcitol | decreases expression | 1 |
| abrine | increases expression | 1 |
| perfluorobutanesulfonic acid | decreases reaction, increases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Estradiol | affects cotreatment, increases expression | 1 |
| Colforsin | increases expression, decreases reaction | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.